| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACKR2
|
atypical chemokine receptor 2
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AKR1C2
|
aldo-keto reductase family 1, member C2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANXA2
|
annexin A2
|
|
ANXA6
|
annexin A6
|
|
APLN
|
apelin
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AR
|
androgen receptor
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4
|
|
ATP5J
|
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEST2
|
bestrophin 2
|
|
BEST3
|
bestrophin 3
|
|
BEST4
|
bestrophin 4
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BHLHA9
|
basic helix-loop-helix family, member a9
|
|
BIN1
|
bridging integrator 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
C10ORF10
|
chromosome 10 open reading frame 10
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1
|
|
C3
|
complement component 3
|
|
CA2
|
carbonic anhydrase II
|
|
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit
|
|
CADM1
|
cell adhesion molecule 1
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CALR
|
calreticulin
|
|
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CASC5
|
cancer susceptibility candidate 5
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNE1
|
cyclin E1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD2
|
CD2 molecule
|
|
CD226
|
CD226 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD58
|
CD58 molecule
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD82
|
CD82 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX2
|
caudal type homeobox 2
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CELF1
|
CUGBP, Elav-like family member 1
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CHGA
|
chromogranin A
|
|
CHMP2B
|
charged multivesicular body protein 2B
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CLDN7
|
claudin 7
|
|
CLOCK
|
clock circadian regulator
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COMT
|
catechol-O-methyltransferase
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRYBB2
|
crystallin, beta B2
|
|
CRYGS
|
crystallin, gamma S
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CST3
|
cystatin C
|
|
CSTB
|
cystatin B (stefin B)
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DAO
|
D-amino-acid oxidase
|
|
DBP
|
D site of albumin promoter (albumin D-box) binding protein
|
|
DEF6
|
differentially expressed in FDCP 6 homolog (mouse)
|
|
DES
|
desmin
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DMD
|
dystrophin
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DSG2
|
desmoglein 2
|
|
DSPP
|
dentin sialophosphoprotein
|
|
DUOX2
|
dual oxidase 2
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
EDN1
|
endothelin 1
|
|
EGFL7
|
EGF-like-domain, multiple 7
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF1
|
eukaryotic translation initiation factor 1
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELN
|
elastin
|
|
ENG
|
endoglin
|
|
ENTPD3
|
ectonucleoside triphosphate diphosphohydrolase 3
|
|
EPHA2
|
EPH receptor A2
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERVFRD-1
|
endogenous retrovirus group FRD, member 1
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
|
FAS
|
Fas cell surface death receptor
|
|
FBLN5
|
fibulin 5
|
|
FBN1
|
fibrillin 1
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FFAR4
|
free fatty acid receptor 4
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGG
|
fibrinogen gamma chain
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FKRP
|
fukutin related protein
|
|
FKTN
|
fukutin
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOXC2
|
forkhead box C2
|
|
FOXP2
|
forkhead box P2
|
|
FRK
|
fyn-related Src family tyrosine kinase
|
|
FRZB
|
frizzled-related protein
|
|
FUS
|
FUS RNA binding protein
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FZD4
|
frizzled class receptor 4
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GALNT1
|
polypeptide N-acetylgalactosaminyltransferase 1
|
|
GAST
|
gastrin
|
|
GDI1
|
GDP dissociation inhibitor 1
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA3
|
gap junction protein, alpha 3, 46kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GLS
|
glutaminase
|
|
GNAS
|
GNAS complex locus
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GNL3L
|
guanine nucleotide binding protein-like 3 (nucleolar)-like
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP1BB
|
glycoprotein Ib (platelet), beta polypeptide
|
|
GP5
|
glycoprotein V (platelet)
|
|
GP9
|
glycoprotein IX (platelet)
|
|
GPR143
|
G protein-coupled receptor 143
|
|
GPR39
|
G protein-coupled receptor 39
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GSTO2
|
glutathione S-transferase omega 2
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GUCY2D
|
guanylate cyclase 2D, membrane (retina-specific)
|
|
GUSB
|
glucuronidase, beta
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC4
|
histone deacetylase 4
|
|
HEXA
|
hexosaminidase A (alpha polypeptide)
|
|
HEXB
|
hexosaminidase B (beta polypeptide)
|
|
HEXDC
|
hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMOX1
|
heme oxygenase 1
|
|
HP
|
haptoglobin
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH4
|
histamine receptor H4
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDE
|
insulin-degrading enzyme
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IER3
|
immediate early response 3
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IL10
|
interleukin 10
|
|
IL11
|
interleukin 11
|
|
IL12A
|
interleukin 12A
|
|
IL13
|
interleukin 13
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL24
|
interleukin 24
|
|
IL33
|
interleukin 33
|
|
IL4
|
interleukin 4
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
INHBB
|
inhibin, beta B
|
|
INSR
|
insulin receptor
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB1BP2
|
integrin beta 1 binding protein (melusin) 2
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
JAG1
|
jagged 1
|
|
JAG2
|
jagged 2
|
|
JAK2
|
Janus kinase 2
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNK18
|
potassium channel, two pore domain subfamily K, member 18
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ1OT1
|
KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)
|
|
KDR
|
kinase insert domain receptor
|
|
KIF11
|
kinesin family member 11
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KL
|
klotho
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT19
|
keratin 19, type I
|
|
LCN2
|
lipocalin 2
|
|
LECT1
|
leukocyte cell derived chemotaxin 1
|
|
LEP
|
leptin
|
|
LEPQTL1
|
Leptin, serum levels of
|
|
LEPR
|
leptin receptor
|
|
LHX6
|
LIM homeobox 6
|
|
LMNA
|
lamin A/C
|
|
LPL
|
lipoprotein lipase
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LYZ
|
lysozyme
|
|
MACROD1
|
MACRO domain containing 1
|
|
MAGEA4
|
melanoma antigen family A4
|
|
MAGEC2
|
melanoma antigen family C2
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPT
|
microtubule-associated protein tau
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
ME1
|
malic enzyme 1, NADP(+)-dependent, cytosolic
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MGAT2
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIR21
|
microRNA 21
|
|
MIR29A
|
microRNA 29a
|
|
MIR9-2
|
microRNA 9-2
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLANA
|
melan-A
|
|
MLH1
|
mutL homolog 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MS4A2
|
membrane-spanning 4-domains, subfamily A, member 2
|
|
MSH2
|
mutS homolog 2
|
|
MT-TK
|
tRNA
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MVP
|
major vault protein
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYLK2
|
myosin light chain kinase 2
|
|
MYO7A
|
myosin VIIA
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NEFH
|
neurofilament, heavy polypeptide
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH2
|
notch 2
|
|
NPC1L1
|
NPC1-like 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NRF1
|
nuclear respiratory factor 1
|
|
NRXN3
|
neurexin 3
|
|
NTSR2
|
neurotensin receptor 2
|
|
OCA2
|
oculocutaneous albinism II
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OSM
|
oncostatin M
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARVA
|
parvin, alpha
|
|
PDCD1
|
programmed cell death 1
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PEPD
|
peptidase D
|
|
PEX26
|
peroxisomal biogenesis factor 26
|
|
PEX5
|
peroxisomal biogenesis factor 5
|
|
PGA3
|
pepsinogen 3, group I (pepsinogen A)
|
|
PGC
|
progastricsin (pepsinogen C)
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PML
|
promyelocytic leukemia
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POLQ
|
polymerase (DNA directed), theta
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDX6
|
peroxiredoxin 6
|
|
PRKCI
|
protein kinase C, iota
|
|
PRL
|
prolactin
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROM1
|
prominin 1
|
|
PRPS1
|
phosphoribosyl pyrophosphate synthetase 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDR
|
prostaglandin D2 receptor (DP)
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK6
|
protein tyrosine kinase 6
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PXN
|
paxillin
|
|
PYY
|
peptide YY
|
|
RAB27B
|
RAB27B, member RAS oncogene family
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RGS19
|
regulator of G-protein signaling 19
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
RPS4Y2
|
ribosomal protein S4, Y-linked 2
|
|
RTN4
|
reticulon 4
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RWDD3
|
RWD domain containing 3
|
|
S100A7
|
S100 calcium binding protein A7
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SCYL1
|
SCY1-like 1 (S. cerevisiae)
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SELPLG
|
selectin P ligand
|
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SGSH
|
N-sulfoglucosamine sulfohydrolase
|
|
SHBG
|
sex hormone-binding globulin
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
|
SLC22A2
|
solute carrier family 22 (organic cation transporter), member 2
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC45A2
|
solute carrier family 45, member 2
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC4A11
|
solute carrier family 4, sodium borate transporter, member 11
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC7A10
|
solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCB
|
synuclein, beta
|
|
SNRPN
|
small nuclear ribonucleoprotein polypeptide N
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRSF3
|
serine/arginine-rich splicing factor 3
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSTR4
|
somatostatin receptor 4
|
|
SSTR5
|
somatostatin receptor 5
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STMN1
|
stathmin 1
|
|
STMN3
|
stathmin-like 3
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
SULT1E1
|
sulfotransferase family 1E, estrogen-preferring, member 1
|
|
TACR3
|
tachykinin receptor 3
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCOF1
|
Treacher Collins-Franceschetti syndrome 1
|
|
TECTA
|
tectorin alpha
|
|
TERT
|
telomerase reverse transcriptase
|
|
TF
|
transferrin
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLK1
|
tousled-like kinase 1
|
|
TLR4
|
toll-like receptor 4
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNNC1
|
troponin C type 1 (slow)
|
|
TNNT3
|
troponin T type 3 (skeletal, fast)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TYR
|
tyrosinase
|
|
TYRP1
|
tyrosinase-related protein 1
|
|
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3
|
|
UCN
|
urocortin
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UMOD
|
uromodulin
|
|
UROD
|
uroporphyrinogen decarboxylase
|
|
UTF1
|
undifferentiated embryonic cell transcription factor 1
|
|
VANGL1
|
VANGL planar cell polarity protein 1
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCAN
|
versican
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIM
|
vimentin
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
VWF
|
von Willebrand factor
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
XIRP1
|
xin actin binding repeat containing 1
|
|
YWHAE
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
|
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
